LLY Q2 2017 Earnings Report — Eli Lilly and Company Revenue & Financial Results | Market Cap Arena

Eli Lilly and CompanyLLY

Q2 2017 Earnings

Reported July 28, 2017

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	Q2 2017	Q1 2017	Q2 2016	QoQ Change	YoY Change
Revenue	$5.8B	$5.2B	$5.4B	11.4%	7.8%
Op. Income	$1.3B	$1.1B	$981M	17.6%	33.9%
Gross Margin	73.0%	74.2%	72.9%	-1.2pp	0.1pp
Net Margin	17.3%	-2.1%	13.8%	19.4pp	3.5pp
EPS (Diluted)	$0.91	$-0.10	$0.68	1010.0%	33.8%
Free Cash Flow	$1.4B	$171M	$1.2B	736.5%	23.6%

Revenue Flow

Item	Amount
REVENUE	$5.8B
Cost of Revenue	$1.6B
GROSS PROFIT	$4.3B
R&D Expenses	$1.3B
Selling & Marketing	$0
General & Administrative	$1.7B
SG&A Expenses	$1.7B
Other Expenses	$0
Operating Expenses	$2.9B
Cost & Expenses	$4.5B
OPERATING INCOME	$1.3B
Interest Income	$37M
Interest Expense	$54M
Other Income/Expenses	-$54M
INCOME BEFORE TAX	$1.3B
Income Tax Expense	$253M
Net Income from Continuing Ops	$1.0B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.0B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.0B
D&A	$396M
EBIT	$1.3B
EBITDA	$1.7B
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$5.8B
Cost of Revenue	$1.6B
GROSS PROFIT	$4.3B
R&D Expenses	$1.3B
Selling & Marketing	$0
General & Administrative	$1.7B
SG&A Expenses	$1.7B
Other Expenses	$0
Operating Expenses	$2.9B
Cost & Expenses	$4.5B
OPERATING INCOME	$1.3B
Interest Income	$37M
Interest Expense	$54M
Other Income/Expenses	-$54M
INCOME BEFORE TAX	$1.3B
Income Tax Expense	$253M
Net Income from Continuing Ops	$1.0B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.0B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.0B
D&A	$396M
EBIT	$1.3B
EBITDA	$1.7B
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$1.0B
Depreciation & Amortization	$396M
Stock-Based Compensation	$70M
Deferred Income Tax	$166M
Other Non-Cash Items	$135M
Change in Working Capital	-$124M
OPERATING CASH FLOW	$1.7B
Capital Expenditure	-$222M
Acquisitions (Net)	$0
Purchases of Investments	-$3.0B
Sales/Maturities of Investments	$1.1B
Other Investing Activities	-$109M
NET CASH FROM INVESTING	-$2.2B
Net Debt Issuance	-$372M
Common Stock Repurchased	-$200M
Common Dividends Paid	-$549M
Other Financing Activities	$2.2B
NET CASH FROM FINANCING	$1.1B
FREE CASH FLOW	$1.4B
Net Change in Cash	$453M

Balance Sheet

Item	Amount
Cash & Equivalents	$3.1B
Short-Term Investments	$2.4B
Net Receivables	$5.0B
Inventory	$4.3B
Other Current Assets	$0
TOTAL CURRENT ASSETS	$15.7B
PP&E (Net)	$8.6B
Goodwill	$4.3B
Intangible Assets	$4.5B
Long-Term Investments	$5.7B
Tax Assets	$0
Other Non-Current Assets	$2.1B
TOTAL NON-CURRENT ASSETS	$25.2B
TOTAL ASSETS	$40.9B
Account Payables	$1.3B
Short-Term Debt	$2.4B
Deferred Revenue	$0
Other Current Liabilities	$6.7B
TOTAL CURRENT LIABILITIES	$11.3B
Long-Term Debt	$9.9B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$0
Other Non-Current Liabilities	$5.6B
TOTAL NON-CURRENT LIABILITIES	$15.5B
TOTAL LIABILITIES	$26.8B
Common Stock	$689M
Additional Paid-In Capital	$5.7B
Retained Earnings	$15.6B
Treasury Stock	-$76M
Accum. Other Comp. Income	-$4.8B
Other Equity	-$3.0B
TOTAL STOCKHOLDERS' EQUITY	$14.1B
Minority Interest	$69M
TOTAL EQUITY	$14.2B
TOTAL LIABILITIES & EQUITY	$40.9B
Total Debt	$12.3B
Net Debt	$9.2B